Pitavastatin + Pravastatin
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Dyslipidemia
Conditions
Dyslipidemia
Trial Timeline
Dec 1, 2010 โ Mar 1, 2013
NCT ID
NCT01301066About Pitavastatin + Pravastatin
Pitavastatin + Pravastatin is a approved stage product being developed by Eli Lilly for Dyslipidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01301066. Target conditions include Dyslipidemia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01301066 | Approved | Completed |
Competing Products
20 competing products in Dyslipidemia